CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Chief Commercial Officer acquired 115,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 125,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 320,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Results of operations · Bylaws or fiscal year change · Other events
- 4 Planned sale Chief Medical Officer sold 5,600 shares at $13.15 ($73,623)
- 4 Planned sale Chief Executive Officer sold 25,791 shares at $13.15 ($339,072)
- 4 Planned sale Chief Legal Officer sold 11,276 shares at $13.15 ($148,244)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Material agreement · Other events
Page 5 of 26 · 506 filings